These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12777264)

  • 1. National trends in the treatment of attention deficit hyperactivity disorder.
    Olfson M; Gameroff MJ; Marcus SC; Jensen PS
    Am J Psychiatry; 2003 Jun; 160(6):1071-7. PubMed ID: 12777264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National trends in the use of outpatient psychotherapy.
    Olfson M; Marcus SC; Druss B; Pincus HA
    Am J Psychiatry; 2002 Nov; 159(11):1914-20. PubMed ID: 12411228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.
    Moreno C; Laje G; Blanco C; Jiang H; Schmidt AB; Olfson M
    Arch Gen Psychiatry; 2007 Sep; 64(9):1032-9. PubMed ID: 17768268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National trends in the outpatient treatment of anxiety disorders.
    Olfson M; Marcus SC; Wan GJ; Geissler EC
    J Clin Psychiatry; 2004 Sep; 65(9):1166-73. PubMed ID: 15367042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.
    Robison LM; Skaer TL; Sclar DA; Galin RS
    CNS Drugs; 2002; 16(2):129-37. PubMed ID: 11825103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
    Comer JS; Olfson M; Mojtabai R
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment services for children with ADHD: a national perspective.
    Hoagwood K; Kelleher KJ; Feil M; Comer DM
    J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):198-206. PubMed ID: 10673831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National trends in outpatient psychotherapy.
    Olfson M; Marcus SC
    Am J Psychiatry; 2010 Dec; 167(12):1456-63. PubMed ID: 20686187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADHD service use patterns in youth.
    Leslie LK; Wolraich ML
    Ambul Pediatr; 2007; 7(1 Suppl):107-20. PubMed ID: 17261490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.
    Chan E; Zhan C; Homer CJ
    Arch Pediatr Adolesc Med; 2002 May; 156(5):504-11. PubMed ID: 11980558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication management of stimulants in pediatric practice settings: a national perspective.
    Hoagwood K; Jensen PS; Feil M; Vitiello B; Bhatara VS
    J Dev Behav Pediatr; 2000 Oct; 21(5):322-31. PubMed ID: 11064959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
    Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
    Robison LM; Sclar DA; Skaer TL; Galin RS
    Int Clin Psychopharmacol; 2004 Jan; 19(1):17-22. PubMed ID: 15101565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National trends in the mental health care of children, adolescents, and adults by office-based physicians.
    Olfson M; Blanco C; Wang S; Laje G; Correll CU
    JAMA Psychiatry; 2014 Jan; 71(1):81-90. PubMed ID: 24285382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.